Cargando…
SARS-CoV-2 antibodies titration: a reappraisal
Autores principales: | Lippi, Giuseppe, Plebani, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475491/ https://www.ncbi.nlm.nih.gov/pubmed/32953832 http://dx.doi.org/10.21037/atm-20-5361 |
Ejemplares similares
-
The many clinical advantages of reporting the cycle threshold (Ct) value
por: Lippi, Giuseppe, et al.
Publicado: (2022) -
Reliability of SARS-CoV-2 serological testing for influencing public health policies: A reappraisal
por: Lippi, Giuseppe, et al.
Publicado: (2023) -
The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
por: Lippi, Giuseppe, et al.
Publicado: (2022) -
Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal
por: Lippi, Giuseppe, et al.
Publicado: (2022) -
Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
por: Lippi, Giuseppe, et al.
Publicado: (2021)